Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 73

1.

Perceptions regarding barriers and facilitators to combination antiretroviral therapy adherence among people living with HIV/AIDS in Gujarat, India: A qualitative study.

Patel S, Baxi RK, Patel SN, Golin CE, Mehta M, Bakshi H, Shingrapure K, Modi E, Coonor P, Mehta K.

Indian J Sex Transm Dis. 2012 Jul;33(2):107-11. doi: 10.4103/0253-7184.102119.

2.

HIV serostatus disclosure: Experiences and perceptions of people living with HIV/AIDS and their service providers in Gujarat, India.

Patel SV, Patel SN, Baxi RK, Golin CE, Mehta M, Shringarpure K, Bakshi H, Modi E, Coonor P, Mehta K.

Ind Psychiatry J. 2012 Jul;21(2):130-6. doi: 10.4103/0972-6748.119615.

3.

Barriers and facilitators to antiretroviral medication adherence among patients with HIV in Chennai, India: a qualitative study.

Kumarasamy N, Safren SA, Raminani SR, Pickard R, James R, Krishnan AK, Solomon S, Mayer KH.

AIDS Patient Care STDS. 2005 Aug;19(8):526-37.

PMID:
16124847
4.

A qualitative assessment of barriers and facilitators to antiretroviral adherence in Thai patients.

Phuphanich M, Rattanamahattana M, Avihingsanon A, Chetchotisakd P, Putcharoen O, Gandhi M, Sohn AH, Imrie J, Phanuphak P, Kerr SJ.

J Virus Erad. 2016 Jan 1;2(1):22-7.

5.
6.

Facilitators and Barriers of Antiretroviral Therapy Initiation among HIV Discordant Couples in Kenya: Qualitative Insights from a Pre-Exposure Prophylaxis Implementation Study.

Patel RC, Odoyo J, Anand K, Stanford-Moore G, Wakhungu I, Bukusi EA, Baeten JM, Brown JM.

PLoS One. 2016 Dec 8;11(12):e0168057. doi: 10.1371/journal.pone.0168057. eCollection 2016.

7.

Fertility Desires and Intentions among People Living with HIV/AIDS (PLWHA) in Southern India.

Jose H, Madi D, Chowta N, Ramapuram J, Bhaskaran U, Achappa B, Chandran V.

J Clin Diagn Res. 2016 Jun;10(6):OC19-22. doi: 10.7860/JCDR/2016/20282.7968. Epub 2016 Jun 1.

8.

The association between combination antiretroviral adherence and AIDS-defining conditions at HIV diagnosis.

Abara WE, Xu J, Adekeye OA, Rust G.

AIDS Care. 2016 Aug;28(8):1013-7. doi: 10.1080/09540121.2016.1139044. Epub 2016 Feb 17.

PMID:
26886075
9.

Living situation affects adherence to combination antiretroviral therapy in HIV-infected adolescents in Rwanda: a qualitative study.

Mutwa PR, Van Nuil JI, Asiimwe-Kateera B, Kestelyn E, Vyankandondera J, Pool R, Ruhirimbura J, Kanakuze C, Reiss P, Geelen S, van de Wijgert J, Boer KR.

PLoS One. 2013;8(4):e60073. doi: 10.1371/journal.pone.0060073. Epub 2013 Apr 3.

10.

[National consensus document by GESIDA/National Aids Plan on antiretroviral treatment in adults infected by the human immunodeficiency virus (January 2011 update)].

Panel de expertos de GESIDA y Plan Nacional sobre el Sida..

Enferm Infecc Microbiol Clin. 2011 Mar;29(3):209.e1-103. doi: 10.1016/j.eimc.2010.12.004. Spanish.

PMID:
21388714
11.

Barriers to and facilitators of adherence to antiretroviral therapy among people living with HIV in Lao PDR: a qualitative study.

Portelli MS, Tenni B, Kounnavong S, Chanthivilay P.

Asia Pac J Public Health. 2015 Mar;27(2):NP778-88. doi: 10.1177/1010539512442082. Epub 2012 Apr 24.

PMID:
22535549
12.

Qualitative analysis of barriers and facilitators encountered by HIV patients in an ART adherence programme.

Krummenacher I, Spencer B, Du Pasquier S, Bugnon O, Cavassini M, Schneider MP.

Int J Clin Pharm. 2014 Aug;36(4):716-24. doi: 10.1007/s11096-014-9930-0. Epub 2014 Jun 10.

PMID:
24913358
13.

Psychosocial factors affecting medication adherence among HIV-1 infected adults receiving combination antiretroviral therapy (cART) in Botswana.

Do NT, Phiri K, Bussmann H, Gaolathe T, Marlink RG, Wester CW.

AIDS Res Hum Retroviruses. 2010 Jun;26(6):685-91. doi: 10.1089/aid.2009.0222.

14.

Accessibility of antiretroviral therapy in Ghana: convenience of access.

Addo-Atuah J, Gourley D, Gourley G, White-Means SI, Womeodu RJ, Faris RJ, Addo NA.

SAHARA J. 2012;9(2):74-87. doi: 10.1080/17290376.2012.683581.

PMID:
23237042
15.
16.
17.

Pharmacy refill adherence compared with CD4 count changes for monitoring HIV-infected adults on antiretroviral therapy.

Bisson GP, Gross R, Bellamy S, Chittams J, Hislop M, Regensberg L, Frank I, Maartens G, Nachega JB.

PLoS Med. 2008 May 20;5(5):e109. doi: 10.1371/journal.pmed.0050109.

18.

Exploring the cultural context of HIV stigma on antiretroviral therapy adherence among people living with HIV/AIDS in southwest Nigeria.

Okoror TA, Falade CO, Olorunlana A, Walker EM, Okareh OT.

AIDS Patient Care STDS. 2013 Jan;27(1):55-64. doi: 10.1089/apc.2012.0150.

PMID:
23305262
19.

"If I have nothing to eat, I get angry and push the pills bottle away from me": A qualitative study of patient determinants of adherence to antiretroviral therapy in the Democratic Republic of Congo.

Musumari PM, Feldman MD, Techasrivichien T, Wouters E, Ono-Kihara M, Kihara M.

AIDS Care. 2013;25(10):1271-7. doi: 10.1080/09540121.2013.764391. Epub 2013 Feb 6.

PMID:
23383757
20.

Adherence to highly active antiretroviral therapy in Hyderabad, India: barriers, facilitators and identification of target groups.

Dworkin MS, Douglas GW, Sabitha Rani GP, Chakraborty A.

Int J STD AIDS. 2016 Mar;27(3):186-95. doi: 10.1177/0956462415578545. Epub 2015 Mar 22.

PMID:
25801316

Supplemental Content

Support Center